Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis
- Ludwig Kappos
- , Douglas L. Arnold
- , Amit Bar-Or
- , A. John Camm
- , Tobias Derfuss
- , Till Sprenger
- , Martin Davies
- , Alexandra Piotrowska
- , Pingping Ni
- , Tomohiko Harada
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations